Clinical characteristics of respiratory syncytial virus infection in neonates and young infants

被引:11
|
作者
Savic, Natasa [1 ]
Jankovic, Borisav [2 ]
Minic, Predrag [1 ]
Vasiljevic, Zorica [3 ]
Sovtic, Aleksandar [1 ]
Pejic, Katarina [2 ]
Sarajlija, Adrijan [4 ]
Gazikalovic, Slobodan [5 ]
机构
[1] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Pulmonol, Belgrade 11070, Serbia
[2] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Neonatol, Belgrade 11070, Serbia
[3] Mother & Child Hlth Inst Dr Vukan Cupic, Lab Clin Microbiol, Belgrade 11070, Serbia
[4] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Metab & Clin Genet, Belgrade 11070, Serbia
[5] Mother & Child Hlth Inst Dr Vukan Cupic, Dept Radiol, Belgrade 11070, Serbia
关键词
respiratory syncytial viruses; infection; infant; newborn; child; preschool; immunologic tests; drug therapy; prognosis; RISK-FACTORS; BRONCHIOLITIS; RSV; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; IMPACT; TRACT; APNEA;
D O I
10.2298/VSP1103220S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Aim. Infection with respiratory syncytial virus (RSV) occurs during the first year of life in 50% of children and 20%-40% of them have signs of lower respiratory tract infection (bronchiolitis or pneumonia). There is an increased risk for complicated course and death from RSV infection in premature infants, especially those with bronchopulmonary dysplasia (BPD) or congenital heart disease. The aim of our study was to analyze clinical characteristics of laboratory confirmed RSV infection in order to evaluate the need for preventive measures in neonates and young infants. Methods. The prospective study included children under age of 12 months admitted to our hospital in the period November 2008 March 2009 who were positive for RSV by enzyme immunoassay membrane test. The course of disease was assessed by clinical score and radiographic findings. Results. Infection with RSV was confirmed in 91 patients: 21 (23.0%) were under the age of 30 days, 37 (40.7%) were between 31-60 days, and 33 patients (36.3%) were older than 60 days (p > 0.05). The highest hospitalization rate was in January - 33 patients (36.3%; p < 0.01). Disease severity score in these age groups (AG) were: 8.4 +/- 0.4 (AG 0-30 days); 9.0 +/- 0.3 (AG 31-60 days) and 8.3 +/- 0.3 (AG > 60 clays), without statistically significant difference among the groups (p > 0.05). Clinical scores in patients with and without risk factors were 10.5 +/- 0.5 and 8.3 +/- 0.2, respectively (p < 0.01).
引用
收藏
页码:220 / 224
页数:5
相关论文
共 50 条
  • [31] EFFECT OF UNDERLYING ILLNESS ON CLINICAL CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION
    MEERT, K
    HEIDEMANN, S
    LIEHLAI, M
    SARNAIK, A
    [J]. PEDIATRIC RESEARCH, 1989, 25 (04) : A41 - A41
  • [32] RETRACTED: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Retracted Article)
    Ventre, K.
    Randolph, A. G.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [33] The Frequency and Clinical Features of Respiratory Syncytial Virus Infection Among Infants Hospitalized with the Diagnosis of Lower Respiratory Tract Infection
    Gulcan, Gulcihan
    Turan, Ozden
    Tukmenoglu, Yelda
    Turkkan, Emine
    Kose, Gulsen
    [J]. GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2015, 13 (02): : 97 - 103
  • [34] Respiratory syncytial virus infection in infants: Perinatal risk factors
    El-Sayer, MS
    Kotb, TM
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 343A - 343A
  • [35] Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection
    Korematsu, Tatsuya
    Koga, Hiroshi
    [J]. VIRUSES-BASEL, 2021, 13 (02):
  • [36] Clinical and Epidemiologic Characteristics of Infants Hospitalized with Respiratory Syncytial Virus Infection During the 2022-2023 Season in Mexico
    Esparza-Miranda, Luis A.
    Juarez-Tobias, Susana
    Munoz-Escalante, Juan C.
    Oliva-Jara, Ulrik A.
    Cadena-Mota, Sandra
    Wong-Chew, Rosa M.
    Noyola, Daniel E.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (10) : E382 - E384
  • [37] Human Milk Oligosaccharides and Respiratory Syncytial Virus Infection in Infants
    Tonon, Karina M.
    Chutipongtanate, Somchai
    Morrow, Ardythe L.
    Newburg, David S.
    [J]. ADVANCES IN NUTRITION, 2024, 15 (06)
  • [38] Prevention and treatment of respiratory syncytial virus infection in infants: an update
    Venkatesh, Mohan Pammi
    Weisman, Leonard E.
    [J]. EXPERT REVIEW OF VACCINES, 2006, 5 (02) : 261 - 268
  • [39] Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
    Rimensberger, PC
    BurekKozlowska, A
    Morell, A
    Germann, D
    Eigenmann, AK
    Steiner, F
    Burger, R
    Kuenzli, M
    Schaad, UB
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) : 209 - 216
  • [40] RESPIRATORY SYNCYTIAL VIRUS-INFECTION CAUSING NEUROLOGICAL DISORDER IN NEONATES
    MORTON, RE
    DINWIDDIE, R
    MARSHALL, WC
    MATTHEW, DJ
    [J]. LANCET, 1981, 1 (8235): : 1426 - 1427